These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9548378)

  • 1. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam.
    Nakamura K; Kurasawa M; Tanaka Y
    Eur J Pharmacol; 1998 Jan; 342(2-3):127-38. PubMed ID: 9548378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam.
    Nakamura K; Kurasawa M
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):521-8. PubMed ID: 10832606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aniracetam restores motivation reduced by satiation in a choice reaction task in aged rats.
    Nakamura K; Kurasawa M
    Pharmacol Biochem Behav; 2001 Jan; 68(1):65-9. PubMed ID: 11274709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats.
    Nakamura K; Shirane M; Koshikawa N
    Brain Res; 2001 Apr; 897(1-2):82-92. PubMed ID: 11282361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like effects of aniracetam in aged rats and its mode of action.
    Nakamura K; Tanaka Y
    Psychopharmacology (Berl); 2001 Nov; 158(2):205-12. PubMed ID: 11702095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP.
    Shirane M; Nakamura K
    Brain Res; 2001 Oct; 916(1-2):211-21. PubMed ID: 11597608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam.
    Nakamura K; Shirane M
    Eur J Pharmacol; 1999 Sep; 380(2-3):81-9. PubMed ID: 10513566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats.
    Furuya Y; Kagaya T; Nishizawa Y; Ogura H
    Brain Res; 1998 Jan; 781(1-2):227-35. PubMed ID: 9507144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
    Ugale RR; Hirani K; Morelli M; Chopde CT
    Neuropsychopharmacology; 2004 Sep; 29(9):1597-609. PubMed ID: 15100702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
    Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.
    Carnoy P; Ravard S; Wemerman B; Soubrie P; Simon P
    Pharmacol Biochem Behav; 1986 Sep; 25(3):503-9. PubMed ID: 2877466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.
    Costall B; Naylor RJ; Nohria V
    Eur J Pharmacol; 1978 Jul; 50(1):39-50. PubMed ID: 28233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
    Pereira M; Siba IP; Chioca LR; Correia D; Vital MA; Pizzolatti MG; Santos AR; Andreatini R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1636-44. PubMed ID: 21689712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats.
    Nakamura K; Kurasawa M; Shirane M
    Brain Res; 2000 Apr; 862(1-2):266-9. PubMed ID: 10799697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interaction of neuroleptics with apomorphine-induced behavior in rats as a function of changing levels of dopamine receptor stimulation.
    Megens AA; Hendrickx HM; Lavreysen H; Langlois X
    J Pharmacol Exp Ther; 2013 Dec; 347(3):681-96. PubMed ID: 24071734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.
    Zhang M; Ballard ME; Unger LV; Haupt A; Gross G; Decker MW; Drescher KU; Rueter LE
    Behav Brain Res; 2007 Aug; 182(1):1-11. PubMed ID: 17570538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: relationship with serotonin and dopamine in the striatum.
    Haleem DJ; Ikram H; Haleem MA
    Brain Res; 2014 Oct; 1586():73-82. PubMed ID: 25160128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.